Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Amyotrophic lateral sclerosis (ALS), formerly known as Lou Gehrig’s disease, is a progressive neurodegenerative condition that profoundly affects motor functions, making effective rehabilitation strategies critical for maintaining quality of life. A recent study published in Nature Scientific Reports sheds light on the transformative role of motor-supported movement exercisers, such as the Thera Trainer Tigo 558, in improving the lives of individuals with ALS.

Understanding Patient-Reported Outcomes (PROs)

In neurorehabilitation and care research, patient-reported outcomes (PROs) are vital tools. They provide direct insight from patients about their health status, quality of life, and the impact of medical interventions. These insights are gathered using patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs), which were central to the study conducted by Maier and colleagues from the Centre for ALS at Charité – Universitätsmedizin Berlin and Ambulanzpartner, a research and care platform for rare neurological diseases.

The Study: A Closer Look

The study evaluated 144 ALS patients who integrated assistive mobility training into their routines using motor-supported movement exercisers. The participants’ usage varied, with 41% using the device 1 to 4 times per week, 42% 5 to 7 times, and 17% more than 7 times weekly. Researchers examined subjective experiences of the therapy, focusing on its impact and the likelihood of patient recommendations.

Key Findings

The results were overwhelmingly positive, highlighting significant benefits in the following areas:

  • Sense of Accomplishment: 67% of participants reported an increased sense of achievement.
  • Reduction in Stiff Limbs: 63% experienced relief from limb stiffness.
  • Improved Mobility: 61% felt a reduction in immobility.
  • Enhanced Well-Being: 55% reported overall better well-being.
  • Decreased Muscle Stiffness: 52% noted reduced muscle stiffness.

Participants with advanced muscle weakness particularly benefited, with many stating that the training helped maintain or improve their muscle power. Notably, 71.6% of participants strongly recommended the training, reflecting high levels of satisfaction and perceived effectiveness.

Addressing Inactivity with Motor Support

One standout feature of the movement exerciser is its ability to integrate passive and assistive exercises through motor support. For ALS patients, who often face significant limitations in active movement, this approach offers a viable alternative to traditional exercise programmes. By addressing the challenges posed by muscle weakness and fatigue, motor-supported training bridges a critical gap in rehabilitation, helping patients stay active and engaged in their care.

The Need for Broader Implementation

Despite its demonstrated benefits, motor-supported movement exercisers are not yet routinely prescribed for ALS patients. This study highlights the need for further research to understand and overcome barriers to early adoption and widespread use. Integrating such devices into standard care protocols could make a significant difference in the holistic treatment of ALS.

A Holistic Approach to ALS Care

The findings underscore the value of incorporating motor-supported movement trainers into ALS treatment plans. By improving mobility, reducing discomfort, and enhancing overall well-being, these devices provide a tangible improvement in quality of life for patients. As healthcare evolves, prioritising innovative and effective therapies like the Thera Trainer Tigo 558 can play a crucial role in ensuring better outcomes for individuals living with ALS.

If you or someone you know could benefit from motor-supported movement training, Beechfield Rehab is here to help. Our team is dedicated to providing tailored solutions that meet the unique needs of each patient. Contact us today to learn more about our offerings and how we can support your journey to improved mobility and well-being.

____________

This blog post is based on information provided by Thera Trainer. For more details on the original article, visit Thera Trainer’s website.

Recent Blog Posts